COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Clinical trial NCT05000216 · TERMINATED

Trial details

NCT number: NCT05000216
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus Vulgaris Multiple Sclerosis (MS)Systemic Sclerosis (SSc)Pediatric SLE Juvenile Idiopathic Arthritis (JIA)Juvenile Dermatomyositis (JDM)Pediatric-Onset Multiple Sclerosis (POMS)

Start date: 2021-08-13
Primary completion: 2023-06-22
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.